November 2, 2023
Psychedelic research has taken place at UC San Diego since the 1970s. But today, thanks to an interdisciplinary team from departments all across campus, that research has expanded to include human clinical trials exploring a range of treatments including chronic pain and mental health.
April 26, 2021
Researchers have created to novel biobanks of diverse tissues from animals to further explore the biological bases and consequences of addiction to cocaine and oxycodone.
March 5, 2020
…reporting on the U.S. opioid epidemic. A journalist with a 30-year career at CBS News who has traveled the globe, Whitaker will share insight with thousands of University of California San Diego graduates as the keynote speaker for the All Campus Commencement on June 13, 2020. Whitaker has covered three…
February 2, 2018
…the U.S.-Mexican border. In the last sixteen years, the opioid epidemic has claimed close to 125,000 lives in the U.S., whereas in Mexico the war on drugs has produced an estimated 200,000 deaths and over 30,000 disappearances in the last decade.
October 14, 2021
The National Institutes of Health (NIH) has awarded researchers at University of California San Diego approximately $30 million over five years to expand and deepen longitudinal studies of the developing brain in children.
May 29, 2018
UC San Diego School of Medicine researchers found that treating mice with a single spinal injection of a protein called AIBP — and thus switching “off” TLR4, a pro-inflammatory molecule — prevented and reversed inflammation and cellular events associated with pain processing. As reported May 29 by Cell Reports, the…
September 17, 2018
…today’s most pressing health challenges, such as antibiotic resistance, opioid abuse and management of mental illness.
August 25, 2020
In a new study from UC San Diego School of Medicine, thousands of fake social media posts tied to COVID-19 and financial scams are found on two popular platforms.
July 8, 2021
Treatment provides non-opiate alternative that is minimally invasive with emphasis on functional restoration.
May 19, 2021
UC San Diego Health is conducting the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.
